Moushami Mallik1,2,3, Marica Catinozzi1,2,3, Clemens B Hug4
1Molecular Neurogenetics Laboratory, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
The study identifies Xrp1 as a modifier of Cabeza (caz) mutant phenotypes in Drosophila, a model for human neurodegenerative diseases like ALS. Xrp1 knockdown rescues motor defects and extends lifespan, suggesting gene expression dysregulation in ALS pathogenesis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: